Insider Buying: Senestech (NASDAQ:SNES) Major Shareholder Buys $328,020.00 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 426,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 15th. The stock was purchased at an average cost of $0.77 per share, with a total value of $328,020.00. Following the completion of the purchase, the insider directly owned 1,505,294 shares of the company’s stock, valued at $1,159,076.38. This represents a 39.47% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Monday, October 19th, Glenbrook Capital Management bought 376,552 shares of Senestech stock. The shares were purchased at an average price of $0.70 per share, for a total transaction of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management purchased 181,252 shares of Senestech stock. The shares were purchased at an average cost of $0.63 per share, for a total transaction of $114,188.76.
• On Friday, August 7th, Glenbrook Capital Management purchased 6,490 shares of Senestech stock. The shares were purchased at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The stock was purchased at an average price of $1.30 per share, with a total value of $19,500.00.

Senestech Stock Performance

Shares of SNES traded up $0.05 during midday trading on Monday, reaching $0.70. The stock had a trading volume of 1,245,150 shares, compared to its average volume of 375,681. The firm has a 50 day simple moving average of $0.93 and a 200-day simple moving average of $1.34. Senestech, Inc. has a one year low of $0.55 and a one year high of $4.04. The firm has a market cap of $3.79 million, a PE ratio of -0.51 and a beta of 0.25. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02.

Senestech (NASDAQ:SNES) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.02. Senestech had a negative net margin of 294.73% and a negative return on equity of 71.89%. The company had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. As a group, sell-side analysts anticipate that Senestech, Inc. will post -1.28 EPS for the current year.

Institutional Investors Weigh In On Senestech

An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC acquired a new position in shares of Senestech, Inc. (NASDAQ:SNES) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech at the end of the most recent reporting period. Institutional investors and hedge funds own 5.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Senestech presently has an average rating of “Sell”.

Senestech Company Profile

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.